我们将经常更新发布内容，以紧跟不断变化的新冠疫情形势。
CRRT 支持
急重症治疗资源
CRRT 资源
出版物
脓毒症和 AKI 中的血液净化技术
儿童危重症肾病和肾脏替代疗法教育
免费精选讲座
Hyperlactatemia: Definitions and Pathophysiology
Lui Forni, MD
Guildford, UK
本报告录制于 AKI & CRRT 2020 大会。
AKI & CRRT 2020 多媒体
_________________
网络研讨会
Innovations in Caring for Patients with Dysnatremias
Javier Neyra, MD, MSCS and Lenar Yessayan, MD, MS
Managing AKI in the Patient with Cancer
Stuart Goldstein, MD and Mitchell Rosner, MD
AKI Biomarker Science is for Smarter People: I’m Just a Guy Trying to Figure Out the In Whom and the When
Stuart Goldstein, MD
新闻
SGLT2 Inhibition and Acute Kidney Injury Friend or Foe?
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of antidiabetic medications that have been demonstrated to improve cardiovascular outcomes in patients with diabetes.
October 20, 2020
Preparing for the Surge Nephrologists Prepare for Fall COVID-19 Surge, Increased Dialysis Demand
“We were completely caught off guard by the proportion of patients with acute kidney injury who required dialysis,” said Sumit Mohan, MD.
October 15, 2020
Higher Creatinine Predicts AKI in Intracerebral Hemorrhage Cases
New strategies aimed at reducing the risk of AKI in patients with ICH may reduce the rates of death or disability associated with ICH.
October 7, 2020
Acute Kidney Injury Ups Risk for Death in COVID-19 Patients
Colleagues assessed survival and kidney outcomes in 9657 adult patients hospitalized with COVID-19 at 13 hospitals in metropolitan New York.
September 29, 2020
日历
2020
40th Annual Meeting of Korean Society of Nephrology (KSN 2020)
September 24, 2020 – September 27, 2020
Seoul Dragon City, Seoul, Korea
ESICM’s 33rd Annual Congress
October 10, 2020 – October 14, 2020
Madrid, Spain
Kidney Week
October 20, 2020 – October 25, 2020
Denver, Colorado, USA
38th Vicenza Course on AKI & CRRT
November 3, 2020 – November 5, 2020
Vicenza, Italy
2021
AKI & CRRT 2021
March 1, 2021 – March 4, 2021
San Diego, California
40th ISICEM
March 16 – March 19, 2021
Brussels, Belgium
关于重症肾脏病学研究进展的国际会议
AKI & CRRT 大会将再次全面探讨重症肾脏病学和 CRRT 快速发展的领域。 它将重点关注我们对各个领域认知的最新进展，包括危重病的病理生理学、急性肾损伤、脓毒血症管理的新策略、多器官衰竭、生物标记物的开发和使用、CRRT 的技术进步以及这些技术的适当利用。 我们的大会采用特约讲座、互动研讨会、专题报告、海报论文展和小组讨论等各种形式，展示用于评估重症患者、肝功能障碍的病理生理学和 AKI 令人振奋的新研究成果和证据。
